Coenzyme Q10 protects human endothelial cells from β-Amyloid uptake and oxidative stress-induced injury

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Durán Prado, Mario ^a,b   Frontiñán, Javier ^a,b   Santiago Mora, Raquel ^a   Peinado, Juan Ramón ^a,b   Parrado Fernández, Cristina ^a,b   Gómez Almagro, María Victoria ^c,d   Moreno, María ^c   López Domínguez, José Alberto ^e   Villalba, José Manuel ^e   Alcaín, Francisco J ^a,b  

^a Universidad de Castilla La Mancha   (Spain)

^b Faculty of Chemistry   (Spain)

^c Instituto Regional de Investigación Cientifica Aplicada Campus Universitario   (Spain)

^d Fundacion Parque Cientifico y Tecnologico de Albacete   (Spain)

^e UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; CALCIUM ION; CYTOCHROME C; HYDROGEN PEROXIDE; OXYGEN; TEMPOL; UBIDECARENONE; UBIQUINONE;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL DEATH; CELL MEMBRANE; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; INJURY; METABOLOMICS; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; OXIDATIVE STRESS; PROTEIN TRANSPORT; ANALOGS AND DERIVATIVES; CYTOLOGY; DRUG EFFECTS; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

AMYLOID BETA-PEPTIDES; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; OXIDATIVE STRESS; UBIQUINONE;

EID: 84907546074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109223     Document Type: Article

References (51)

1. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430: 631-639.
2. Park L, Anrather J, Forster C., Kazama K, Carlson GA, et al. (2004) Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex. J Cereb Blood Flow Metab 24: 334-342.
3. Biron KE, Dickstein DL, Gopaul R, Jefferies WA (2011) Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS One 6: e23789.
4. Marchesi VT (2011) Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. The FASEB Journal 25: 5-13.
5. Suo Z, Fang C, Crawford F., Mullan M (1997) Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity. Brain Res 762: 144-152.
6. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827.
7. Akiyama H, Ikeda K, Kondo H., McGeer PL (1992) Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett 146: 152-154.
8. Rizzo MT, Leaver HA (2010) Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and disease. Mol Neurobiol 42: 52-63.
9. Hsu M-J, Hsu C.Y., Chen B-C, Chen M-C, Ou G, et al. (2007) Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis. J Neurosci 27: 5719-5729.
10. Blanc EM, Toborek M, Mark R.J., Hennig B., Mattson MP (1997) Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 68: 1870-1881.
11. Xu J, Chen S, Ku G., Ahmed SH, Chen H, et al. (2001) Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab 21: 702-710.
12. Bhatia R, Lin H, Lal R (2000) Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J 14: 1233-1243.
13. Kawahara M (2010) Neurotoxicity of b-amyloid protein: oligomerization, channel formation, and calcium dyshomeostasis. Cur Pharm Des 16: 2779-2789.
14. Lal R, Lin H, Quist AP (2007) Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. Biochim Biophys Acta 1768: 1966-1975.
15. Park L, Anrather J, Zhou P., Frys K, Pitstick R, et al. (2005) NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 25: 1769-1777.
16. Belliere J, Devun F, Cottet-Rousselle C, Batandier C., Leverve X, et al. (2012) Prerequisites for ubiquinone analogs to prevent mitochondrial permeability transition-induced cell death. J Bioenerg Biomembr 44: 207-212.
17. Li G, Zou LY, Cao C.M., Yang ES (2005) Coenzyme Q10 protects SHSY5Y neuronal cells from beta amyloid toxicity and oxygen-glucose deprivation by inhibiting the opening of the mitochondrial permeability transition pore. Biofactors 25: 97-107.
18. Cha MY, Han SH, Son S.M., Hong HS, Choi YJ, et al. (2012) Mitochondria-specific accumulation of amyloid beta induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 7: e34929.
19. Hansson Petersen CA, Alikhani N, Behbahani H., Wiehager B, Pavlov PF, et al. (2008) The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci U S A 105: 13145-13150.
20. Grammas P (2011) Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation 8: 26.
21. Dai YL, Luk TH, Yiu K.H., Wang M., Yip PM, et al. (2011) Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Atherosclerosis 216: 395-401.
22. Gao L, Mao Q, Cao J., Wang Y, Zhou X, et al. (2012) Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis 221: 311-316.
23. Tiano L, Belardinelli R, Carnevali P., Principi F, Seddaiu G, et al. (2007) Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 28: 2249-2255.
24. Tsai KL, Chen LH, Chiou S.H., Chiou GY, Chen YC, et al. (2011) Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway. Mol Nutr Food Res 55 Suppl 2: S227-240.
25. Tsai KL, Huang YH, Kao C.L., Yang DM, Lee HC, et al. (2012) A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways. J Nutr Biochem 23: 458-468.
26. Tsuneki H, Sekizaki N, Suzuki T., Kobayashi S, Wada T, et al. (2007) Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells. Eur J Pharmacol 566: 1-10.
27. Tsuneki H, Tokai E, Suzuki T., Seki T, Okubo K, et al. (2013) Protective effects of coenzyme Q10 against angiotensin II-induced oxidative stress in human umbilical vein endothelial cells. Eur J Pharmacol 701: 218-227.
28. Fontaine E, Ichas F, Bernardi P (1998) A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J Biol Chem 273: 25734-25740.
29. Naderi J, Somayajulu-Nitu M, Mukerji A., Sharda P, Sikorska M, et al. (2006) Water-soluble formulation of Coenzyme Q10 inhibits Bax-induced destabilization of mitochondria in mammalian cells. Apoptosis 11: 1359-1369.
30. Barth BM, Gustafson SJ, Kuhn TB (2012) Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-alpha. J Neurosci Res 90: 229-242.
31. Arroyo A, Navarro F, Gomez-Diaz C, Crane F.L., Alcain FJ, et al. (2000) Interactions between ascorbyl free radical and coenzyme Q at the plasma membrane. J Bioenerg Biomembr 32: 199-210.
32. Bello RI, Gomez-Diaz C, Buron M.I., Alcain FJ, Navas P, et al. (2005) Enhanced anti-oxidant protection of liver membranes in long-lived rats fed on a coenzyme Q10-supplemented diet. Exp Gerontol 40: 694-706.
33. Patel NS, Quadros A, Brem S., Wotoczek-Obadia M, Mathura VS, et al. (2008) Potent anti-angiogenic motifs within the Alzheimer beta-amyloid peptide. Amyloid 15: 5-19.
34. Folin M, Baiguera S, Tommasini M., Guidolin D, Conconi MT, et al. (2005) Effects of beta-amyloid on rat neuromicrovascular endothelial cells cultured in vitro. Int J Mol Med 15: 929-935.
35. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5: 347-360.
36. Kandimalla KK, Scott OG, Fulzele S, Davidson M.W., Poduslo JF (2009) Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein. PLoS One 4: e4627.
37. Trushina E, Nemutlu E, Zhang S., Christensen T, Camp J, et al. (2012) Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's Disease. PLoS ONE 7.
38. Villalba JM, Parrado C, Santos-Gonzalez M, Alcain FJ (2010) Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opin Investig Drugs 19: 535-554.
39. Simakova O, Arispe NJ (2011) Fluorescent analysis of the cell-selective Alzheimer's disease ab Peptide surface membrane binding: influence of membrane components. Int J Alzheimer's Dis 2011: 917629-917629.
40. Fernandez-Ayala DJ, Brea-Calvo G, Lopez-Lluch G, Navas P (2005) Coenzyme Q distribution in HL-60 human cells depends on the endomembrane system. Biochim Biophys Acta 1713: 129-137.
41. Mason RP, Estermyer JD, Kelly J.F., Mason PE (1996) Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis. Biochem Biophys Res Commun 222: 78-82.
42. Genova ML, Lenaz G (2011) New developments on the functions of coenzyme Q in mitochondria. Biofactors 37: 330-354.
43. Anantharaman M, Tangpong J, Keller J.N., Murphy MP, Markesbery WR, et al. (2006) Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. Am J Pathol 168: 1608-1618.
44. Mugoni V, Postel R, Catanzaro V., De Luca E, Turco E, et al. (2013) Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis. Cell 152: 504-518.
45. Burklen TS, Schlattner U, Homayouni R., Gough K, Rak M, et al. (2006) The Creatine Kinase/Creatine Connection to Alzheimer's Disease: CK Inactivation, APP-CK Complexes, and Focal Creatine Deposits. J Biomed Biotechnol 2006.
46. Lupo G, Anfuso CD, Assero G, Strosznajder R.P., Walski M., et al. (2001) Amyloid beta(1-42) and its beta(25-35) fragment induce in vitro phosphatidyl-choline hydrolysis in bovine retina capillary pericytes. Neurosci Lettr 303: 185-188.
47. Wong MK, Gotlieb AI (1984) In vitro reendothelialization of a single-cell wound. Role of microfilament bundles in rapid lamellipodia-mediated wound closure. Lab Invest 51: 75-81.
48. Drummond GR, Selemidis S, Griendling K.K., Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10: 453-471.
49. Hamilton SJ, Chew GT, Watts GF (2009) Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care 32: 810-812.
50. Lim SC, Lekshminarayanan R, Goh S.K., Ong YY, Subramaniam T, et al. (2008) The effect of coenzyme Q10 on microcirculatory endothelial function of subjects with type 2 diabetes mellitus. Atherosclerosis 196: 966-969.
51. Langsjoen PH (2000) Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 35: 816-817.